-
Overview of the procurement completion progress and usage proportion of 157 nationally sourced varieties
Time of Update: 2021-09-12
2. The second batch of national procurement The second batch of national procurement of Jiangxi selected drugs will enter the second procurement cycle from April 11, 2021, from April 11, 2021 to July 31, 2021, procurement The situation is as follows: Purchase quantity and amount .
-
With the reduction of wild resources, the contradiction between supply and demand of Acanthopanax senticosus has reached a critical point
Time of Update: 2021-09-12
After entering the 21st century, with the continuous deepening of scientific research, the use of Acanthopanax senticosus has been expanded to varying degrees, the market share has increased day by day, and the demand has also shown an upward trend year by year .
-
The market for all fields of medicine has increased by 17.9%!
Time of Update: 2021-09-12
1 2012-2021 Q2 China's major cities drawing a sample hospital sales growth analysis we analyze each treatment according to ATC classification categories of the market, the first half of 2021, anti- cancer drugs and immune regulation inhibitors, and the whole digestive tract and systemic anti-infective drug metabolism The sales of drugs were 25.
-
The status quo of the protection of special medicines for "Huiminbao", big data interpretation of 126 products!
Time of Update: 2021-09-12
At the same time, the compensation limit and payment ratio of the "Huiminbao" liability for special drugs are also not closely related to product prices .
-
1.5 billion oral hypoglycemic drugs welcome spoilers!
Time of Update: 2021-09-12
Medical News, September 1st, August 30th, the official website of the State Food and Drug Administration showed that Tonghua Dongbao Pharmaceutical was approved for imitation of Sitagliptin phosphate tablets for production in Category 4, and was deemed to have been reviewed .
-
Eight departments issued the "Deepening Medical Service Price Reform Pilot Program"!
Time of Update: 2021-09-12
Answer: The "Pilot Plan" requires that people's health is the center, clinical value is the direction, and the law of medical development is the law, to establish and improve to adapt to economic and social development, to better play the role of the government, to fully participate in medical institutions, and to reflect the value of technical labor services.
-
Huge indemnities up to 160 million US dollars!
Time of Update: 2021-09-12
5 million in compensation Compared with the "huge compensation" of foreign companies such as Abbott and Medtronic, in contrast to domestic medical device procurement corruption cases, few domestic companies have paid the price for this, which is extremely ironic .
-
391 pharmaceutical companies posted transcripts for the first half of the year, 18 gross profit margins exceeded 90%
Time of Update: 2021-09-12
have also reached new highs; 13 companies such as Zhifei Bio, Mindray Medical, and Hengrui Pharmaceutical have net The profit exceeded 2 billion yuan; the gross profit margin of 18 companies including Ellis, Biotech, and Wuwu Biotech exceeded 90% .
-
Hengrui 1.3 billion "shopping"!
Time of Update: 2021-09-12
The cooperation with Dalian Wanchun is also regarded by the outside world as Hengrui Pharmaceuticals is leveraging local emerging pharmaceutical companies to break through innovative research and development, and it is also Sun Piaoyang's plan to implement his good medicine .
-
Fosun holds 5 top explosives, 72 innovative drugs and 18 biosimilar drugs
Time of Update: 2021-09-12
As an established pharmaceutical company, Fosun Pharma's generic drugs are also facing the impact of centralized procurement, and innovative products have become a strong "blood transfusion" support .
In the first half of the year, the sales revenue of Fosun Pharma's anti-tumor and immunomodulation core products increased by 256.
-
Livzon innovative drugs sold over 5 billion!
Time of Update: 2021-09-12
According to the company's annual report data, after several years of polishing and accumulation after being approved for listing, the sales of ilaprazole enteric-coated tablets successfully exceeded 100 million yuan in 2014, and it has grown into a new growth point for the company's performance; in 2018, the injection formulation was officially launched.
-
Guangxi included 531 traditional Chinese medicine and ethnic medicine decoction pieces into the payment scope of medical insurance and work-related injury insurance funds
Time of Update: 2021-09-12
The bureau, together with the Human Resources and Social Security Department of Guangxi Zhuang Autonomous Region, issued relevant notices to include 531 traditional Chinese medicine and ethnic medicine decoction pieces that meet the conditions and have Guangxi local standards into the Guangxi basic medical insurance (including Maternity insurance) and the scope of payment from the work-related injury insurance fund .
-
The State Food and Drug Administration Revises the Instructions for Creatine Phosphate Sodium for Injection
Time of Update: 2021-09-12
Medical Network September 3 News State Food and Drug Administration announcement on the revision of muscle sodium phosphate injection instructions (2021 No.
105) according to Drug assessment of adverse reactions, to further protect public safety, the State Drug Administration decided The contents of the instructions for creatine phosphate sodium for injection have been revised and improved uniformly .
-
Jiangsu Province Solicits Opinions and Suggestions on Drug Safety Credit Management Measures
Time of Update: 2021-09-12
Medical Network News, August 31, August 25, Jiangsu Provincial Drug Administration issued an announcement on the "Jiangsu Province Drug Safety Credit Management Measures (Draft for Solicitation of Co
-
Jilin Province Solicits Opinions on the Implementation Rules for the Management of Traditional Chinese Medicine Formula Granules
Time of Update: 2021-09-12
Article 12 If the Chinese medicine formula granules produced by other province's Chinese medicine formula granule production enterprises enter the medical institutions of Jilin Province for use, they shall be reported to the Provincial Drug Administration for the record, and the production enterprises and their varieties that have not been recorded shall not be sold and used in Jilin Province .
-
In the first half of the year, Xinjiang’s “cross-province and remote” medical settlement expenses exceeded 3 billion yuan
Time of Update: 2021-09-12
Xing Xiaoliang, director of the Medical Service Management Office of Xinjiang Medical Security Bureau, said: "According to the unified arrangement of the National Medical Insurance Bureau , chronic diseases such as diabetes and hypertension , which involve a large number of people and are commonly developed in localities, will be included in the settlement of cross-provincial and remote locations, so as to increase the number of people insured to seek medical treatment in different places.
-
The growth cycle is short, and the price of turmeric continues to rise, and there is great resistance!
Time of Update: 2021-09-12
Bozhou market: Affected by the off-season, the purchase and sales of turmeric in the market have moved generally in the near future, which is not as good as the previous period.
-
The State Administration of Market Supervision Solicits Opinions on the Enforcement Guidelines for Medical Beauty Advertisements
Time of Update: 2021-09-12
6. In the process of medical cosmetology advertisement supervision, the market supervision department shall promptly notify the health administrative department at the same level if it is found that the medical cosmetology institution has not obtained the practice license or has not been filed to engage in medical cosmetology activities .
-
50 billion!
Time of Update: 2021-09-12
According to incomplete statistics, 319 A-share and Hong Kong-listed pharmaceutical companies announced H1 R&D investment in 2021 (see the end of the article for details), with a total amount of nearly 50 billion yuan , Hengrui, Fosun, CSPC, Cinda and other blockbuster Class 1 new drugs are submitted for production .
-
For hospitals above level 2 in Ningbo, the security check coverage rate should reach 100%
Time of Update: 2021-09-12
Similar to Ningbo, in July this year, the Zhejiang Yueqing City Health Bureau also issued the "Notice on Printing and Distributing the Work Plan for the Construction of Large-scale Hospital Security System in Yueqing City in 2021", proposing to improve the intelligent security system, scientifically and orderly carry out security inspection work, Establish an early warning mechanism for key populations .
